AI Product

PathAI — Digital Pathology

AI-powered digital pathology platform for analyzing histopathology slides, supporting diagnostic workflows, biomarker assessment, and pharmaceutical research use cases.

Intelligence Summary

Product
  • Active
  • Verified public sources
  • Developer PathAI
  • Category Digital Pathology
  • Status Active
  • Latest update 2016: PathAI founded in Boston by Andrew Beck.
  • Documentation Official page
  • Last reviewed Jul 2026
5 Technologies

Official product page

Target customer

Pathology laboratories, health systems, diagnostic companies, and pharmaceutical researchers using digitized tissue samples.

Features & capabilities

Industries: AI in Healthcare; Digital Pathology

Related reports

Related insights

Overview

AI-powered digital pathology platform for analyzing histopathology slides, supporting diagnostic workflows, biomarker assessment, and pharmaceutical research use cases.

Product and company

PathAI — Digital Pathology is a verified product offering linked to the Brel Digital company profile for PathAI.

Use cases

AI-powered digital pathology platform for analyzing histopathology slides, supporting diagnostic workflows, biomarker assessment, and pharmaceutical research use cases.

Target customer

Pathology laboratories, health systems, diagnostic companies, and pharmaceutical researchers using digitized tissue samples.

Technologies

Primary technologies assigned from the linked company profile: Computer Vision, Deep Learning, Healthcare Analytics, Machine Learning, Medical Imaging.

Sources and references

  • Official product / company source: https://www.roche.com/media/releases/med-cor-2026-05-07
  • Supporting source: https://www.pathai.com

Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.

Last reviewed

This product profile was last reviewed on 2026-07-14.

Correction request

If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.

Features and capabilities

  • AI-powered digital pathology platform for analyzing histopathology slides, supporting diagnostic workflows, biomarker assessment, and pharmaceutical research use cases.

Extracted from the linked company product description already verified on Brel. No capabilities were invented.

Sources and references

This article draws on publicly available company information, official websites, filings, interviews, announcements, and other cited sources. Information may change over time.

Enquire about this product profile

Messages are delivered to contact@breldigital.com.